NeuroSense Therapeutics Ltd. Gains 48.81%
Mon, Jun 27, 2022 at 08:30 PM
NeuroSense Therapeutics Ltd. (NRSN:NASDAQ) shot up at $2.5, a gain of 48.8%. On Mon, Jun 27, 2022, NRSN:NASDAQ touched a New 2-Week High of $2.5. The stock got featured on our News Catalysts scanner on Mon, Jun 27, 2022 at 08:49 AM in the 'EARNINGS' category. From Tue, Jun 14, 2022, the stock recorded 75.00% Up Days and 66.67% Green Days
The stock spiked on Mon, Jun 27, 2022 at $3.3 with a volume of 99M+.
About NeuroSense Therapeutics Ltd. (NRSN:NASDAQ)
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these...
Top 10 Gainers:
- Evofem Biosciences, Inc. (EVFM:NASDAQ), 187.71%
- Acutus Medical Inc. (AFIB:NASDAQ), 87.59%
- Epizyme, Inc. (EPZM:NASDAQ), 55.14%
- Axsome Therapeutics, Inc. (AXSM:NASDAQ), 51.39%
- NeuroSense Therapeutics Ltd. (NRSN:NASDAQ), 48.81%
- Bellerophon Therapeutics, Inc. (BLPH:NASDAQ), 42.39%
- InflaRx N.V. (IFRX:NASDAQ), 38.28%
- Kiromic BioPharma Inc. (KRBP:NASDAQ), 36.14%
- Visionary Education Technology Holdings Group Inc. (VEDU:NASDAQ), 33.16%
- Aspira Women's Health Inc. (AWH:NASDAQ), 32.39%